Smith H J, Lorite M J, Tisdale M J
Pharmaceutical Sciences Institute, Aston University, Birmingham, United Kingdom.
Cancer Res. 1999 Nov 1;59(21):5507-13.
The effect of a proteolysis inducing factor (PIF) on protein synthesis and degradation and the modulation of this effect by the polyunsaturated fatty acid, eicosapentaenoic acid (EPA), have been examined using a surrogate model system, C2C12 myoblasts in vitro. After 90 min of incubation, PIF produced a significant inhibition of protein synthesis in a dose-dependent manner, with maximal inhibition at a concentration of 4 nM. The effect was attenuated both by treatment with a monoclonal antibody to PIF and by treatment with insulin at physiological concentrations (1 nM) and below (0.1 nM), but not by EPA (50 microM). The inhibitory effect on protein synthesis was transitory and was not seen after prolonged incubation with PIF. An increased rate of protein degradation was observed in C2C12 myoblasts after addition of PIF, which was also maximal at a concentration of PIF of 4 nM. Higher concentrations of PIF did not produce an increase in protein degradation. Unlike the effect on protein synthesis, the enhanced protein degradation was completely abolished by pretreatment with 50 microM EPA, suggesting that the two effects are mediated by different mechanisms. PIF produced an increased release of [3H]arachidonic acid from prelabeled myoblasts with a dose-response curve parallel to that of protein degradation and with a maximum at 4 nM PIF. Release of [3H] arachidonic acid was completely blocked in cells pretreated with 50 microM EPA, suggesting that the effect was related to protein degradation. The [3H]arachidonic acid was rapidly metabolized to prostaglandins E2 and F2alpha and to 5-, 12-, and 15-hydroxyeicosatetraenoic acids (HETEs). Production of all eicosanoids was attenuated in cells pretreated with EPA. Of all of the metabolites, only 15-HETE produced a significant increase in protein degradation in C2C12 myoblasts with a maximal effect at 30 nM and with a bell-shaped dose-response curve similar to that produced by PIF. These results suggest that PIF enhances protein degradation as a result of an increased production of 15-HETE.
利用体外替代模型系统C2C12成肌细胞,研究了蛋白水解诱导因子(PIF)对蛋白质合成与降解的影响,以及多不饱和脂肪酸二十碳五烯酸(EPA)对该影响的调节作用。孵育90分钟后,PIF以剂量依赖方式显著抑制蛋白质合成,在浓度为4 nM时抑制作用最大。用抗PIF单克隆抗体处理以及用生理浓度(1 nM)及以下(0.1 nM)的胰岛素处理,均可减弱该作用,但EPA(50 μM)处理则无此效果。对蛋白质合成的抑制作用是短暂的,长时间与PIF孵育后则未观察到该作用。添加PIF后,C2C12成肌细胞中蛋白质降解速率增加,在PIF浓度为4 nM时也达到最大。更高浓度的PIF并未使蛋白质降解增加。与对蛋白质合成的作用不同,用50 μM EPA预处理可完全消除增强的蛋白质降解,这表明这两种作用是由不同机制介导的。PIF使预标记的成肌细胞中[3H]花生四烯酸的释放增加,其剂量反应曲线与蛋白质降解的曲线平行,在PIF浓度为4 nM时达到最大值。用50 μM EPA预处理的细胞中,[3H]花生四烯酸的释放完全被阻断,这表明该作用与蛋白质降解有关。[3H]花生四烯酸迅速代谢为前列腺素E2和F2α以及5-、12-和15-羟基二十碳四烯酸(HETEs)。在用EPA预处理的细胞中,所有类花生酸的产生均减弱。在所有代谢产物中,只有15-HETE使C2C12成肌细胞中的蛋白质降解显著增加,在30 nM时作用最大,其剂量反应曲线呈钟形,与PIF产生的曲线相似。这些结果表明,PIF由于15-HETE产生增加而增强了蛋白质降解。